Dr. Djamila Harouaka
Sr. Scientific Advisor, CDER/OPQ/OQS/FDA
Djamila Harouaka is the Senior Scientific Advisor in the Office of Quality Surveillance (OQS) in the Office of Pharmaceutical Quality (OPQ) in FDA’s Center for Drug Evaluation and Research (CDER). In her current role, she provides scientific and technical advice and consultation regarding program matters and complex issues related to pharmaceutical quality surveillance. Djamila also served as a microbiologist in CDER’s Office of Compliance (OC) where she assessed the compliance status of compounding pharmacies and performed high-priority inspections. In addition to her routine work, she also led the development of technical training courses delivered through the Compounding Quality Center of Excellence including the courses on Environmental Monitoring and Aseptic Process Simulations. Djamila began her FDA career in the Office of Regulatory Affairs (ORA), where she worked as a certified Drug Investigator. She earned her PhD in Microbiology from the University of Alabama at Birmingham.